Advisory Committee

Report From FINRA Board of Governors Meeting – May 2023

Retrieved on: 
Thursday, May 25, 2023
Public Policy, Government, Other Professional Services, Legal, Personal Finance, Finance, Law Enforcement, Emergency Services, Professional Services, Fintech, University, Advisory Committee, Defense Policy Board Advisory Committee, Human, Multimedia, Research, Ropes & Gray, Regulation, Rope, University of Pennsylvania Law School, Business association, FINRA, Law, Institute for Law and Finance, Security (finance), Policy, Financial adviser

FINRA’s Board of Governors met on May 17-18 for the second time in 2023.

Key Points: 
  • FINRA’s Board of Governors met on May 17-18 for the second time in 2023.
  • During the meeting, the Board appointed a new public governor, approved FINRA’s 2022 Annual Financial Report and added new members to Advisory Committees.
  • Her research and scholarly interests include matters related to corporate and board governance, board fiduciary duties, board-shareholder engagement, board composition and diversity, board oversight, shareholder engagement and activism, affinity fraud, and securities fraud.
  • The next FINRA Board of Governors meeting is scheduled for July.

ICCSD: Leveraging the Power of AI for Sustainable Development across Multiple Sectors

Retrieved on: 
Friday, May 26, 2023
Online, UNESCO, United Nations, International Center, Information technology, Advisory Committee, GCN, Humanities, Research, CRI, ICCSD, Sustainable Development Goals, United Nations Secretariat, Creativity, Professor, Federal Advisory Committee Act, Machine learning, UN, School, Adviser, Artificial intelligence, Tongji University, AI, Sustainable development, Peking University, Beijing University of Posts and Telecommunications, Tourism, Telecommunications, Architecture

Attendees came together to explore the profound impact of artificial intelligence (AI) technology in advancing sustainable development in the modern era.

Key Points: 
  • Attendees came together to explore the profound impact of artificial intelligence (AI) technology in advancing sustainable development in the modern era.
  • Recognizing the potential of emerging technologies, many have called for their integration to expedite the SDGs.
  • Zhao Haiying, Professor at the School of Artificial Intelligence at Beijing University of Posts and Telecommunications, delivered a presentation on harnessing the power of AI to unlock the realms of cultural computing and cultural heritage.
  • By synergizing big data, AI, machine learning, and cultural history, the intricate nuances of cultural connotations could be explored, advancing the field of digital humanities research.

ICCSD: Harnessing the Power of AI for Enhanced Cultural Heritage Preservation

Retrieved on: 
Friday, May 26, 2023
Online, UNESCO, Digital divide, International Center, Public policy, University of the Chinese Academy of Sciences, Rzhanov Institute of Semiconductor Physics, Advisory Committee, IOS, ChatGPT, Dean, Royal Society, CRI, Royal, ICCSD, President's Science Advisory Committee, Technology management, Creativity, Biodiversity, Professor, Division, School, Tsinghua University, CAS, Artificial intelligence, City, AI, Sustainable development, Tsinghua University School of Public Policy and Management, Medical device, Science

At the event, experts from diverse fields came together to explore the applications of artificial intelligence (AI) across various domains.

Key Points: 
  • At the event, experts from diverse fields came together to explore the applications of artificial intelligence (AI) across various domains.
  • Shahbaz Khan, Director of the UNESCO Office Beijing, emphasized the potential of digitalization and AI to strengthen the preservation of cultural heritage, highlighting the significant progress made by ICCSD in this area.
  • Richard Leaver, an AI scientist and Fellow of the Royal Society, shed light on the latest advancements that ChatGPT can offer, discussing its technical implications and the benefits it brings to individuals and communities.
  • Their efforts have yielded new scientific and technological tools that benefit bird researchers, conservationists, and the general public, significantly enhancing the efficiency of biodiversity monitoring and conservation efforts.

ICCSD Convenes Advisory Committee Meeting to Explore AI's Role in Empowering Sustainable Development

Retrieved on: 
Friday, May 26, 2023
UNESCO, Strategic planning, International Center, Chinese Academy of Sciences, Rzhanov Institute of Semiconductor Physics, Advisory Committee, IOS, Royal Society, Chinese Academy of Agricultural Sciences, Research, Multimedia, Technology management, Assistant, Creativity, Biodiversity, Division, Water, CAS, Artificial intelligence, FRSA, AI, Transport, Sustainable development, Royal, Medical device, Science, ICCSD

BEIJING, May 25, 2023 /PRNewswire/ -- A report from CRIOnline:

Key Points: 
  • BEIJING, May 25, 2023 /PRNewswire/ -- A report from CRIOnline:
    On May 23, the conference of the Advisory Committee of the International Center for Creativity and Sustainable Development (ICCSD) under the auspices of UNESCO was held in a hybrid format.
  • Members of the committee's board and guests gathered to delve into the future of ICCSD and the transformative power of artificial intelligence (AI) technology in advancing sustainable development in the new era.
  • The ICCSD aims to bridge the gap between tech culture and sustainable development, fostering exchanges among experts in diverse fields to collectively explore and unlock the full potential of AI.
  • The ICCSD Advisory Committee Chairman, Mr. d'Orville, said that AI is already being used to address many global and regional environmental problems in areas like biodiversity, water, energy, and transportation.

Intercept Announces Outcome of FDA Advisory Committee Meeting for Obeticholic Acid as a Treatment for Pre-Cirrhotic Fibrosis due to NASH

Retrieved on: 
Friday, May 19, 2023
Intercept, Therapy, NASH, Advisory Committee, NDA, Patient, Intercept Pharmaceuticals, OCA, PDUFA, Fatty liver disease, FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, National Institutes of Technology (India), Food, Safety, Pharmaceutical industry

MORRISTOWN, N.J., May 19, 2023 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced the outcome of the U.S. Food and Drug Administration (FDA) Gastrointestinal Drugs Advisory Committee (GIDAC) Meeting to review the Company’s New Drug Application (NDA) for obeticholic acid (OCA) for the treatment of pre-cirrhotic fibrosis due to nonalcoholic steatohepatitis (NASH).

Key Points: 
  • “We continue to disagree with the FDA on certain characterizations of OCA’s efficacy and safety in pre-cirrhotic fibrosis due to NASH and the role of non-invasive tests (NITs), as discussed in today's meeting.
  • As previously reported, the FDA has assigned a Prescription Drug User Fee Act (PDUFA) Target Action Date of June 22, 2023.
  • The conference call will be available via a listen-only webcast on the investor page of the company’s website at http://ir.interceptpharma.com .
  • A replay of the call will be available on the Intercept website shortly following the completion of the call and will be available for one year.

Intercept Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee to Review Obeticholic Acid as a Treatment for Pre-Cirrhotic Fibrosis due to NASH

Retrieved on: 
Friday, May 19, 2023
Therapy, NASH, Advisory Committee, NDA, Intercept Pharmaceuticals, OCA, PDUFA, Fatty liver disease, FDA, Food, Pharmaceutical industry

The U.S. Food and Drug Administration’s (FDA) Gastrointestinal Drugs Advisory Committee (GIDAC) is meeting today to review obeticholic acid (OCA) as a treatment for pre-cirrhotic fibrosis due to nonalcoholic steatohepatitis (NASH).

Key Points: 
  • The U.S. Food and Drug Administration’s (FDA) Gastrointestinal Drugs Advisory Committee (GIDAC) is meeting today to review obeticholic acid (OCA) as a treatment for pre-cirrhotic fibrosis due to nonalcoholic steatohepatitis (NASH).
  • The Advisory Committee meeting is scheduled for 9:00 a.m. - 5:00 p.m.
  • As previously reported, the FDA has assigned a Prescription Drug User Fee Act (PDUFA) target action date of June 22, 2023.
  • Trading of the company’s common stock will resume at the discretion of NASDAQ.

Pacsun Announces Executive Changes Effective June 15, 2023

Retrieved on: 
Thursday, May 18, 2023
Storm, Merchandising, Anderson School of Management, Max Azria, Music, Omnichannel, Vice, Partnership, Gen, Senior, Kid, Formula One, Advanced Management Program, Advisory Committee, COVID-19, Risk management, Information technology, Golden Gate Capital, Harvard Business School, Generation Z, Pulse, Business administration, 2022 Miami Grand Prix, Formula, Hanna Andersson, CFO, Miami Grand Prix, Guessing, Russell Bowers, Sport, LOS, UCLA, Woman, Master of Business Administration, Management, Operation, Finance, PacSun

LOS ANGELES, May 18, 2023 /PRNewswire/ -- Pacsun today announced a series of leadership changes whereby Brie Olson, Pacsun Co-Chief Executive Officer and Board member, will be appointed Chief Executive Officer, effective June 15, 2023. Mike Relich will retire as Co-CEO and will continue to serve on the Pacsun Board of Directors in a new role as Vice Chairman. Russell Bowers will be appointed Chief Operating Officer and will continue to serve as Pacsun Chief Financial Officer, overseeing Finance, Operations, and Information Technology functions in his expanded role.  

Key Points: 
  • Mike Relich to Retire as Co-CEO; Will Transition to Vice Chairman on Pacsun Board
    Russell Bowers Appointed Chief Operating Officer; Will Continue to Serve as CFO
    LOS ANGELES, May 18, 2023 /PRNewswire/ -- Pacsun today announced a series of leadership changes whereby Brie Olson, Pacsun Co-Chief Executive Officer and Board member, will be appointed Chief Executive Officer, effective June 15, 2023.
  • Ms. Olson has over two decades of experience in the retail industry, including 17 years at Pacsun.
  • She has served as Co-CEO since March 2023, and before that as President and a Board member since May 2021.
  • During her tenure with Pacsun, Ms. Olson introduced Pacsun's first gender neutral collection, Colour Theory, and oversaw Pacsun's entry into the Kids' category with Pacsun Kids.

Nominations Revealed for the 2023 SSIMAs

Retrieved on: 
Tuesday, May 16, 2023
Music, Food, National Arts Centre, TD, Culture, Advisory Committee, Anishinaabe, History, Sale, National Indigenous Peoples Day, NAC, NIPD, Entrepreneurship, Toronto-Dominion Bank, Juno Award for Indigenous Artist or Group of the Year, Summer, VIP, Film industry, Entertainment

Aysanabee leads with six nominations, Snotty Nose Rez Kids follow with five

Key Points: 
  • Aysanabee leads with six nominations, Snotty Nose Rez Kids follow with five
    OTTAWA, ON, May 16, 2023 /CNW/ - The Summer Solstice Indigenous Festival today announced nominees for The SSIMAs, (Summer Solstice Indigenous Music Awards) presented by TD Bank Group.
  • Winners will be celebrated and honoured in Ottawa during the awards ceremony at the National Arts Centre on Tuesday, June 6th, 2023.
  • The SSIMAs span 16 categories, celebrating solo artists, duos and groups from across Canada and showcasing the diverse and growing music and culture of artistic expression and accomplishment within the Indigenous community.
  • Hosted by Anishinaabe activist, broadcaster and content creator Sarain Fox, The SSIMAs presentation ceremony will feature six live performances.

Lassen Peak Appoints Former London Metropolitan Police Deputy Assistant Commissioner, Graham McNulty QPM, to its Advisory Committee for the United Kingdom

Retrieved on: 
Tuesday, May 16, 2023
Lassen Peak, Weapon, Afghan Local Police, Left–right political spectrum, Queen, Advisory Committee, Law enforcement, Policy, Crime, Privacy, Police, Metropolitan, QPM, United Kingdom, Organizing, NPCC, National Police Chiefs' Council, Drug, Private investigator, Scotland Yard

BELLEVUE, Wash., May 16, 2023 /PRNewswire/ -- Today, Lassen Peak announces the appointment of Graham McNulty to its Advisory Committee for the United Kingdom. Throughout his 30-year career, Mr. McNulty has been an active leader in the U.K. policing community, including holding the National Police Chiefs' Council (NPCC) Lead for Knife-Enabled Crime and Gangs. In January 2022, Mr. McNulty was awarded the Queen's Police Medal (QPM) by Her Majesty Queen Elizabeth II.

Key Points: 
  • BELLEVUE, Wash., May 16, 2023 /PRNewswire/ -- Today, Lassen Peak announces the appointment of Graham McNulty to its Advisory Committee for the United Kingdom.
  • In January 2022, Mr. McNulty was awarded the Queen's Police Medal (QPM) by Her Majesty Queen Elizabeth II.
  • "This technology will allow police officers to stop the right people, focusing on individuals intent on causing harm."
  • Mr. McNulty brings a wealth of relevant experience to the Lassen Peak Advisory Committee.

Health Canada Accepts New Drug Submission for Lecanemab as Treatment for Early Alzheimer's Disease

Retrieved on: 
Tuesday, May 16, 2023
Priority review, The New England Journal of Medicine, Plaque, NDS, Alzheimer's disease, MHLW, Marketing, Neurotoxicity, Food, Advisory Committee, European Medicines Agency, Medicines and Healthcare products Regulatory Agency, Lecanemab, Ministry of Health, Labour and Welfare, Brain, Medication, Pharmaceuticals and Medical Devices Agency, Oncology Drug Advisory Committee, EMA, Clarity, Ministry, Eisai, The Different Forms of Flowers on Plants of the Same Species, Prescription Drug User Fee Act, PMDA, National Medical Products Administration, Co-promotion, PDUFA, Ministry of Health (Kuwait), MAA, AD, FDA, Phase, Health Canada, BLA, NMPA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Disease, Medical imaging, Pharmaceutical industry, Biogen, Health

Lecanemab selectively binds and eliminates soluble, toxic Aβ aggregates (protofibrils) that are thought to contribute to the neurotoxicity in AD.

Key Points: 
  • Lecanemab selectively binds and eliminates soluble, toxic Aβ aggregates (protofibrils) that are thought to contribute to the neurotoxicity in AD.
  • As such, lecanemab may have the potential to have an effect on disease pathology and to slow down the progression of the disease.
  • The Clarity AD study of lecanemab met its primary endpoint and all key secondary endpoints with highly statistically significant results.
  • Lecanemab was approved under the accelerated approval pathway in the U.S. and was launched in the U.S. on January 18, 2023.